Although there are numerous suggestions that the ECM promotes cancer cell migration and invasion through FAK signalling, the mechanism by which ECM fibronectin regulates FAK activity in lung cancer cells, particularly in relation to calpain-2 and RhoA, has not yet been explored in detail. This evidence concerns the gene CAPN2 and lung cancer.